A multicentre, phase III, randomised controlled trial of radiotherapy and concomitant Temodal (temozolomide) or neoadjuvant chemotherapy followed by radiotherapy and concomitant Temodal in patients with high grade glioma.

Trial Profile

A multicentre, phase III, randomised controlled trial of radiotherapy and concomitant Temodal (temozolomide) or neoadjuvant chemotherapy followed by radiotherapy and concomitant Temodal in patients with high grade glioma.

Completed
Phase of Trial: Phase III

Latest Information Update: 20 Sep 2011

At a glance

  • Drugs Temozolomide (Primary)
  • Indications Anaplastic astrocytoma; Glioblastoma
  • Focus Therapeutic Use
  • Most Recent Events

    • 20 Sep 2011 Additional lead trial center identified as reported by ISRCTN.
    • 30 Sep 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top